CN103384521A - 用于预防和治疗骨关节炎的方法和组合物 - Google Patents

用于预防和治疗骨关节炎的方法和组合物 Download PDF

Info

Publication number
CN103384521A
CN103384521A CN2011800680315A CN201180068031A CN103384521A CN 103384521 A CN103384521 A CN 103384521A CN 2011800680315 A CN2011800680315 A CN 2011800680315A CN 201180068031 A CN201180068031 A CN 201180068031A CN 103384521 A CN103384521 A CN 103384521A
Authority
CN
China
Prior art keywords
dgla
animal
composition
administered
probiotics
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2011800680315A
Other languages
English (en)
Chinese (zh)
Inventor
R·P·米德尔顿
M·K·沃尔德伦
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nestec SA
Original Assignee
Societe dAssistance Technique pour Produits Nestle SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe dAssistance Technique pour Produits Nestle SA filed Critical Societe dAssistance Technique pour Produits Nestle SA
Publication of CN103384521A publication Critical patent/CN103384521A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Physiology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN2011800680315A 2010-12-21 2011-12-15 用于预防和治疗骨关节炎的方法和组合物 Pending CN103384521A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201061459902P 2010-12-21 2010-12-21
US61/459,902 2010-12-21
PCT/US2011/065173 WO2012087745A1 (en) 2010-12-21 2011-12-15 Methods and compositions for preventing and treating osteoarthritis

Publications (1)

Publication Number Publication Date
CN103384521A true CN103384521A (zh) 2013-11-06

Family

ID=46314373

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2011800680315A Pending CN103384521A (zh) 2010-12-21 2011-12-15 用于预防和治疗骨关节炎的方法和组合物

Country Status (11)

Country Link
US (1) US20140205569A1 (enExample)
EP (1) EP2654744A4 (enExample)
JP (1) JP2014505679A (enExample)
CN (1) CN103384521A (enExample)
AU (1) AU2011349718B2 (enExample)
BR (1) BR112013018453A2 (enExample)
CA (1) CA2822263A1 (enExample)
MX (1) MX2013007191A (enExample)
RU (1) RU2013133998A (enExample)
WO (1) WO2012087745A1 (enExample)
ZA (1) ZA201305497B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0907413D0 (en) 2009-04-29 2009-06-10 Equateq Ltd Novel methods
US8293790B2 (en) 2011-10-19 2012-10-23 Dignity Sciences Limited Pharmaceutical compositions comprising DGLA and benzoyl peroxide and methods of use thereof
WO2014022816A2 (en) * 2012-08-03 2014-02-06 Dignity Sciences Limited Pharmaceutical compositions comprising 15-hetre and methods of treating or preventing arthritis using same
JP2017516823A (ja) 2014-06-04 2017-06-22 ディグニティ サイエンシス リミテッド Ｄｇｌａを含む薬学的組成物及びその使用
US20210315851A1 (en) 2020-04-03 2021-10-14 Afimmune Limited Compositions comprising 15-hepe and methods of treating or preventing hematologic disorders, and/or related diseases

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1111508A (zh) * 1994-03-01 1995-11-15 斯科舍集团有限公司 脂肪酸衍生物
WO1998018751A1 (en) * 1996-10-30 1998-05-07 Scotia Holdings Plc Presentation of bioactives

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE49783B1 (en) * 1979-05-18 1985-12-11 Efamol Ltd Pharmaceutical and dietary composition comprising epsilon-linolenic acids
GB9403857D0 (en) * 1994-03-01 1994-04-20 Scotia Holdings Plc Fatty acid derivatives
KR100458659B1 (ko) * 1995-08-07 2005-06-27 산토리 가부시키가이샤 오메가9계불포화지방산을포함하는연골조직의이상에기인하는의학적증상의예방또는개선작용을갖는음식품및이의제조방법
GB9710351D0 (en) * 1997-05-20 1997-07-16 Scotia Holdings Plc Glucosamine fatty acids
ES2262667T3 (es) * 2000-05-25 2006-12-01 Societe Des Produits Nestle S.A. Probioticos nuevos para aplicaciones en alimento para animales de compañia.
US20020188024A1 (en) * 2000-08-23 2002-12-12 Chilton Floyd H. Fatty acid-containing emulsion with increased bioavailability
BRPI0413287A (pt) * 2003-08-11 2006-10-10 Hills Pet Nutrition Inc métodos de restaurar uma função da articulação que é mais próxima do normal em um cão apresentando osteoartrite, e de eliminar a probabilidade de um cão desenvolver osteoartrite, e, uso de ácido eicosapentaenóico (epa)
US8633247B2 (en) * 2003-08-11 2014-01-21 Hill's Pet Nutrition, Inc. Method for decreasing cartilage damage in dogs
CA2546968A1 (en) * 2003-11-21 2005-06-16 Nestec S.A. Food composition comprising glucosamine
JP5667737B2 (ja) * 2004-07-01 2015-02-12 ネステク ソシエテ アノニム イヌ変形性関節症食餌製剤
EP3581178B1 (en) * 2005-02-14 2023-08-30 Suntory Holdings Limited Composition containing dihomo-(gamma)-linolenic acid (dgla) as active ingredient
CN101460185A (zh) * 2006-04-03 2009-06-17 雀巢产品技术援助有限公司 用于促进骨生长和维持骨健康的营养组合物及与其有关的方法

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1111508A (zh) * 1994-03-01 1995-11-15 斯科舍集团有限公司 脂肪酸衍生物
WO1998018751A1 (en) * 1996-10-30 1998-05-07 Scotia Holdings Plc Presentation of bioactives

Also Published As

Publication number Publication date
CA2822263A1 (en) 2012-06-28
EP2654744A1 (en) 2013-10-30
WO2012087745A1 (en) 2012-06-28
AU2011349718A1 (en) 2013-07-04
MX2013007191A (es) 2013-07-12
EP2654744A4 (en) 2014-07-02
AU2011349718B2 (en) 2017-02-09
RU2013133998A (ru) 2015-01-27
BR112013018453A2 (pt) 2018-05-22
ZA201305497B (en) 2015-01-28
JP2014505679A (ja) 2014-03-06
US20140205569A1 (en) 2014-07-24

Similar Documents

Publication Publication Date Title
CN103384529B (zh) 适合于控制动物血糖的方法和组合物
RU2605330C2 (ru) Способы и композиции, подходящие для укрепления здоровья кожи
JP2014515011A (ja) 加齢に伴う疾病を改善するのに有用な組成物及び方法
CN106998747A (zh) 用于在重量减轻期间保持瘦体重并促进减脂的方法和组合物
CN106793800A (zh) 用于增强运动性或活动性或者治疗体弱的组合物和方法
AU2011349718B2 (en) Methods and compositions for preventing and treating osteoarthritis
JP6923440B2 (ja) 中鎖トリグリセリドを含むてんかんの治療用の組成物及び方法
CN103917230A (zh) 改善应激引起的症状或情况的方法
AU2009249582B2 (en) Methods for reducing lipid absorption by an animal
WO2012039745A1 (en) Methods and compositions for preventing or treating osteoarthritis
JP2014519494A (ja) 除脂肪量の増大を促進するための方法及び組成物
JP2025531817A (ja) 動物に健康上の効果を提供するための南洋サバ油を利用した組成物及び方法
WO2012060884A1 (en) Methods and compositions for preventing and treating osteoarthritis
WO2013052433A2 (en) Methods and compositions for reducing food intake and body weight gain in animals
CN103619169A (zh) 用于在减肥期间保持瘦体重的方法和组合物
CN115884769A (zh) 用于向动物提供健康益处的组合物和方法
WO2012067641A2 (en) Methods and compositions for preventing and treating osteoarthritis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20131106

RJ01 Rejection of invention patent application after publication